Results 301 to 310 of about 151,741 (352)
Some of the next articles are maybe not open access.

Calcium channel blockers in psychiatry

Psychosomatics, 1987
Abstract Calcium channel blockers have an established role in the treatment of various cardiovascular disorders and potential applications in psychiatry. Preliminary reports based on limited numbers of patients indicate that they are promising for mania, of uncertain utility for depression or schizophrenia, and deserving of further investigation for ...
M H, Pollack, J F, Rosenbaum, S E, Hyman
openaire   +2 more sources

Chromatography of calcium channel blockers

Journal of Chromatography B: Biomedical Sciences and Applications, 1990
Numerous publications during the past ten years have described the determination of various calcium channel blockers in biological fluids, using gas and liquid chromatographic techniques. Diltiazem, verapamil, flunarizine and a growing number of dihydropyridines belong to this group of drugs, which in most instances are active at low plasma ...
M, Ahnoff, B A, Persson
openaire   +2 more sources

Calcium channel blockers and calcium channels

2004
In 1883, Ringer showed that to get isolated hearts to contract, it was necessary to have Ca2+ ions in the perfusion medium [421]. This was the first demonstration of the critical role of calcium in cellular activity. Remarkably, a hundred years passed before the importance of calcium was recognized in processes other than muscle contraction, and almost
Eric Ertel, Théophile Godfraind
openaire   +1 more source

Calcium channel blockers in psychiatry

1996
The influence of calcium in mental disorders has been considered over time. For example, intravenous calcium gluconate was used for treatment of periodic psychosis as late as the 1970s. Also, mental symptoms may be prominent in patients with hypercalcemia of various causes.
L E, Hollister, E S, Garza-Trevino
openaire   +2 more sources

Differentiation of Calcium Entry Blockers into Calcium Channel Blockers and Calcium Overload Blockers

European Neurology, 1986
The heterogeneity of the several subgroups of calcium-antagonistic drugs requires a rigid and well-defined differentiation of this type of agents. From the chemical point of view verapamil-like drugs, dihydropyridines, benzothiazepines and diphenylalkylamines should be distinguished.
openaire   +2 more sources

Calcium Channel Blocker Toxicity

Pediatric Emergency Care, 2009
Calcium channel blockers continue to be used for the management of a wide variety of adult and pediatric conditions including hypertension, angina pectoris, atrial arrhythmias, Raynaud phenomenon, and migraine headaches. With increased use comes increased potential for misuse and abuse.
Anna Maria, Arroyo, Louise W, Kao
openaire   +2 more sources

Calcium channel blockers and atherogenesis

The American Journal of Medicine, 1987
The events involved in atherogenesis include platelet deposition on damaged endothelial surfaces; migration and proliferation of smooth muscle cells; the formation of elastin, collagen, and glycosaminoglycans, followed by the penetration and complexing of lipoproteins; and, calcification.
openaire   +2 more sources

Calcium channel blockers: an update

The American Journal of Medicine, 2004
This paper reviews the current literature pertaining to calcium channel blockers, including their classification, properties, and therapeutic indications, in light of several recent trials that have addressed their safety. Calcium channel blockers are a structurally and functionally heterogeneous group of medications that are used widely to control ...
Mark J, Eisenberg   +2 more
openaire   +2 more sources

Review of Calcium-Channel Blockers

The Nurse Practitioner, 1986
Calcium-channel blocking drugs were introduced to the United States in 1982. The three approved calcium-channel blockers--nifedipine, verapamil and diltiazem--have offered new treatments for angina. This article presents an overview of these drugs with emphasis on their mechanisms of action, clinical use and guidelines for the nurse practitioner in ...
openaire   +2 more sources

Calcium channel blockers and asthma

Lung, 1986
An increase in cytoplasmic Ca++ concentration can activate not only respiratory smooth muscles, but also mast cells, bronchial mucus glands, and the vagi. Altered control of cytoplasmic Ca++ may also be related to the development of bronchial hyperreactivity.
So, SY, Ip, M, Lam, WK
openaire   +4 more sources

Home - About - Disclaimer - Privacy